QUAD GENERIC DRUG TRIAL: SHAH FOUND GUILTY, BANSAL ACQUITTED
QUAD GENERIC DRUG TRIAL: SHAH FOUND GUILTY, BANSAL ACQUITTED May 9 after a four week trial and five days of jury deliberation before Baltimore federal court Judge Peter Messitte. Former Quad President Dilip Shah was found guilty of making a false statement to FDA concerning Quad's vancomycin HCl. Bansal was acquitted of conspiracy to defraud the U.S. government. He is the only defendant brought to trial by the Justice Department in its generic drug investigations to be acquitted.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth